About
Cell-Penetrating Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
25
By Phase
PHASE1: 1
By Status
TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Locations (1)
Headquarters
Daejeon, Korea
Map
Loading map...